DJE Kapital’s Johnson & Johnson JNJ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$204M Buy
767,300
+256,618
+50% +$67.7M 3.88% 9
2026
Q2
$134M Sell
510,682
-240,762
-32% -$56.1M 2.53% 10
2026
Q1
$183M Sell
751,444
-74,935
-9% -$17.5M 4.05% 5
2025
Q4
$171M Buy
826,379
+804,245
+3,634% +$159M 4.73% 3
2025
Q3
$3.37M Hold
22,134
– – 0.08% 85
2025
Q2
$3.37M Buy
22,134
+2,770
+14% +$426K 0.08% 85
2025
Q1
$3.22M Hold
19,364
– – 0.1% 85
2024
Q4
$2.79M Buy
+19,364
New +$3M 0.07% 92

Other funds holding JNJ

DJE Kapital's JNJ Position: Q3 2026 in Review

DJE Kapital increased its Johnson & Johnson (JNJ) stake by 50% in Q3 2026, buying an estimated $67.7M and bringing the position to 767,300 shares worth $204M. The position accounts for 3.88% of the portfolio, ranked #9.

DJE Kapital first reported a position in JNJ in Q4 2024 and has held it in 8 quarters since. 4,734 funds tracked by Wall St. Rank hold JNJ as of Q3 2026.

  • DJE Kapital held 767,300 shares of Johnson & Johnson worth $204M as of Q3 2026.
  • DJE Kapital bought 256,618 Johnson & Johnson shares in Q3 2026, an estimated $67.7M.
  • Johnson & Johnson made up 3.88% of DJE Kapital's portfolio in Q3 2026, its #9 holding.
  • DJE Kapital first reported a position in Johnson & Johnson in Q4 2024 and has held it in 8 quarters since.
  • 4,734 funds tracked by Wall St. Rank held Johnson & Johnson as of Q3 2026.

Based on DJE Kapital's 13F filing for Q3 2026, filed 12 Nov 2026.